19 reports

  • WOMEN'S HEALTH MARKET IN EUROPE

Its oncology clinical pipeline includes therapies for various types of cancers such as breast cancer, ovarian cancer, non-small cell lung cancer, and blood cancers.

  • Contraceptive
  • Allergan plc
  • Bayer AG
  • Merck & Co., Inc.
  • Pfizer Inc.

In FY2014, the company conducted clinical trials for the R& D of drugs for breast cancer, liver cancer, non-Hodgkin lymphoma, prostate cancer, renal cell cancer.

  • Contraceptive
  • Actavis plc
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Teva Pharmaceuticals Ltd.
  • Market challenges

Also, oral contraceptives may increase the risk of breast cancer.

  • Contraceptive
  • World
  • Allergan plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Top-ranked women health issues 2015
  • Increasing investments in women's health

In December 2014, the company received approval from the FDA for GARDASIL## (HPV ##-valent vaccine, recombinant) for the prevention of cervical, vulvar, vaginal, and anal cancers in girls and young women.

  • Contraceptive
  • Allergan plc
  • Mylan Inc.
  • Pfizer Inc.
  • Teva Pharmaceuticals Ltd.
  • 06. TYPES OF CONTRACEPTIVE METHODS

cancer, eye diseases, pulmonary hypertension, high blood pressure, and infectious diseases), and contraceptives.

  • Contraceptive
  • Actavis plc
  • Ansell Limited
  • Church & Dwight Co., Inc.
  • Merck & Co., Inc.

Cancer Helps Reduce Risk of Endometrial Cancer Increases Risk of Ischemic Stroke Heightens the Risk of Crohn’s Disease Oral Contraceptives - Challenges & Strategies to Overcome Problems Rising Need to Develop Contraceptives for Men Drive Robust Research & Development

  • Contraceptive
  • Europe
  • United States
  • World
  • Trade
  • Market landscape

TYPE Advantages and disadvantages of different types of contraceptives ADVANTAGES DISADVANTAGES VAGINAL RINGS STERILIZATION Long lasting (up to five years) Coitus not affected Estrogen-free May decrease risk of endometrial cancer May prevent precancerous cells in the uterus Effective and pe

  • Condom
  • Contraceptive
  • World
  • Market Size
  • Female Health Company

Advantages and disadvantages of different types of contraceptives Type Advantages Disadvantages STERILIZATION Long lasting (up to five years) Coitus not affected Estrogen-free May decrease risk of endometrial cancer May prevent precancerous cells in the uterus Rarely, the uterus may be perf

  • Contraceptive
  • OTC
  • World
  • Market Size
  • 2.7 DISADVANTAGES OF COMBINED HORMONAL CONTRACEPTIVES
  • 2.8 CONTRAINDICATIONS

The company successfully launched cancer drug Stivarga™ in other countries, and recorded the first sales of the cancer drug Xofigo™ (2013 sales: US$##. ## million).

  • Contraceptive
  • United States
  • Actavis plc
  • Bayer AG
  • Merck & Co., Inc.

Another sexual enhancement product, namely DHEA is known to cause ovarian, breast, and prostate cancers among women.

  • Contraceptive
  • World
  • Ansell Limited
  • Church & Dwight Co., Inc.
  • Reckitt Benckiser Group plc

In 2014, the Cancer Research UK' s Translational Cancer Research Prize was awarded to Dr.

  • Contraceptive
  • Therapy
  • United States
  • Company
  • GlobalData's company

It provides treatment concepts for the hormonal treatment of breast and prostate cancer in women.

  • Contraceptive
  • Pharmaceutical
  • Europe
  • United States
  • Mithra
  • LEVOSERT - CONTRACEPTION - PRODUCT DESCRIPTION

A randomized controlled study using L-Dex is currently underway at six leading cancer centers, including the Vanderbilt-Ingram Cancer Center, University of Texas MD Anderson Cancer Center, Mayo Clinic, University of Kansas Cancer Center, VCU Massey

  • Clinical Trial
  • Contraceptive
  • Therapy
  • United States
  • GlobalData's company
  • Female Contraception - Pipeline by Orbis Biosciences Inc, H2 2016
  • receive Estelle (E4/DRSP) during 12 months.

The drug candidate in Phase I stage of development for the treatment of migraine and prostate cancer.

  • Contraceptive
  • Hormone
  • United States
  • Product Initiative
  • Mithra
  • Orbis Biosciences Inc
  • Female Contraception - Pipeline by Orbis Biosciences Inc, H1 2017

For osteoporosis, breast cancer, prostate cancer and migraine PCT application has been filed under number WO 2003/ ##, WO 2004/ ##, WO 2004/ ## and WO 2007/ ##.

  • Contraceptive
  • Hormone
  • United States
  • Product Initiative
  • Mithra
  • 5.1 BY TYPE

These patches are also ##. ##. ##. ## OTHERS associated with increased protection against anemia, ovarian cysts, pelvic inflammatory disease, iron deficiency and endometrial and ovarian cancer.

  • Contraceptive
  • United Arab Emirates
  • Company
  • Forecast
  • Pfizer Inc.
  • 5.1 INTRODUCTION

ParaGard ##. ##. ## C o p p e r I U D Will remain in place of insertion for about ##years Can be removed anytime with ease Reduces risk of cervical cancer, endometrial cancer, and so on No risk of side effects Can be used as an emergency contraception Can be inserted after delivery

  • Contraceptive
  • OTC
  • Europe
  • World
  • Actavis plc

For osteoporosis, breast cancer, prostate cancer and migraine PCT application has been filed under number WO 2003/ ##, WO 2004/ ##, WO 2004/ ## and WO 2007/ ##.

  • Contraceptive
  • Hormone
  • United States
  • Product Initiative
  • BioSante Pharmaceuticals, Inc.

For osteoporosis, breast cancer, prostate cancer and migraine PCT application has been filed under number WO 2003/ ##, WO 2004/ ##, WO 2004/ ## and WO 2007/ ##.

  • Contraceptive
  • Hormone
  • Research And Development
  • United States
  • Product Initiative